ALK and ROS1 concurrent with EGFR mutation in patients with lung adenocarcinoma
Yanjiao Mao, Shixiu Wu Department of Radiotherapy Oncology, Hangzhou Cancer Hospital, Hangzhou, People’s Republic of China Purpose: The purpose of this study was to explore the frequencies of ALK and ROS1 fusion genes in EGFR-mutant lung adenocarcinoma patients and examine the therapeuti...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2017-07-01
|
| Series: | OncoTargets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/alk-and-ros1-concurrent-with-egfr-mutation-in-patients-with-lung-adeno-peer-reviewed-article-OTT |